Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant α-2b interferon and doxorubicin: Results of a pilot study
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9), 1319-1325
- https://doi.org/10.1016/0959-8049(94)90181-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Phase I study of recombinant leukocyte a interferon (IFN-α2A, roferon-A) with doxorubicin in advanced malignant diseaseCancer, 1989
- Progress toward therapeutic application of interferons, 1979–1983Cancer, 1984
- Hepatocellular CarcinomaArchives of Surgery, 1984
- Interferons in the treatment of human cancer.Journal of Clinical Oncology, 1984
- Chemotherapy for advanced hepatocellular carcinoma Adriamycin versus quadruple chemotherapyCancer, 1984
- Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assayCancer Chemotherapy and Pharmacology, 1983
- Combined interferon-antimetabolite therapy of murine L1210 leukemiaCancer, 1981
- Reporting results of cancer treatmentCancer, 1981
- Efficacy of combined interferon cyclophosphamide therapy after diagnosis of lymphoma in AKR miceEuropean Journal of Cancer (1965), 1978
- Clinical manifestations of hepatoma: A review of 6 years' experience at a cancer hospitalThe American Journal of Medicine, 1974